Trial · NCT04440592
Adverse events78
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
21 to 40 of 78
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | MT-7117 | 3 | 38 | |
| other | Nasopharyngitis | Infections and infestations | Placebo | 5 | 38 | |
| other | Upper respiratory tract infection | Infections and infestations | MT-7117 | 2 | 38 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 2 | 38 | |
| other | Accidental overdose | Injury, poisoning and procedural complications | MT-7117 | 0 | 38 | |
| other | Accidental overdose | Injury, poisoning and procedural complications | Placebo | 4 | 38 | |
| other | Gamma-glutamyltransferase increased | Investigations | MT-7117 | 0 | 38 | |
| other | Gamma-glutamyltransferase increased | Investigations | Placebo | 2 | 38 | |
| other | Decreased appetite | Metabolism and nutrition disorders | MT-7117 | 2 | 38 | |
| other | Decreased appetite | Metabolism and nutrition disorders | Placebo | 1 | 38 | |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | MT-7117 | 2 | 38 | |
| other | Hypercholesterolaemia | Metabolism and nutrition disorders | Placebo | 0 | 38 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | MT-7117 | 2 | 38 | |
| other | Muscle spasms | Musculoskeletal and connective tissue disorders | Placebo | 0 | 38 | |
| other | Systemic scleroderma | Musculoskeletal and connective tissue disorders | MT-7117 | 0 | 38 | |
| other | Systemic scleroderma | Musculoskeletal and connective tissue disorders | Placebo | 2 | 38 | |
| other | Dysplastic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MT-7117 | 2 | 38 | |
| other | Dysplastic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 38 | |
| other | Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MT-7117 | 12 | 38 | |
| other | Melanocytic naevus | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 2 | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04440592/events?page=2